A broad investigation of the HBV-mediated changes to primary hepatocyte physiology reveals HBV significantly alters metabolic pathways.
A broad investigation of the HBV-mediated changes to primary hepatocyte physiology reveals HBV significantly alters metabolic pathways.
复制标题
DOI:
10.1016/j.metabol.2018.01.007
复制
发表时间:
2018-06
期刊:
影响因子:
--
通讯作者:
Bouchard MJ
中科院分区:
文献类型:
--
作者:
Lamontagne RJ;Casciano JC;Bouchard MJ
As the leading risk factor for the development of liver cancer, chronic infection with hepatitis B virus (HBV) represents a significant global health concern. Although an effective HBV vaccine exists, at least 240 million people are chronically infected with HBV worldwide. Therapeutic options for the treatment of chronic HBV remain limited, and none achieve an absolute cure. To develop novel therapeutic targets, a better understanding of the complex network of virus-host interactions is needed. Because of the central metabolic role of the liver, we assessed the metabolic impact of HBV infection as a means to identify viral dependency factors and metabolic pathways that could serve as novel points of therapeutic intervention. Primary rat hepatocytes were infected with a control adenovirus, an adenovirus expressing a greater-than-unit-length copy of the HBV genome, or an adenovirus expressing the HBV × protein (HBx). A panel of 369 metabolites was analyzed for HBV- or HBx-induced changes 24 and 48 hours post infection. Pathway analysis was used to identify key metabolic pathways altered in the presence of HBV or HBx expression, and these findings were further supported through integration of publically available gene expression data. We observed distinct changes to multiple metabolites in the context of HBV replication or HBx expression. Interestingly, a panel of 7 metabolites (maltotriose, maltose, myristate [14:0], arachidate [20:0], 3-hydroxybutyrate [BHBA], myo-inositol, and 2-palmitoylglycerol [16:0]) were altered by both HBV and HBx at both time points. In addition, incorporation of data from a transcriptome-based dataset allowed us to identify metabolic pathways, including long chain fatty acid metabolism, glycolysis, and glycogen metabolism, that were significantly altered by HBV and HBx. Because the liver is a central regulator of metabolic processes, it is important to understand how HBV replication and HBV protein expression affects the metabolic function of hepatocytes. Through analysis of a broad panel of metabolites we investigated this metabolic impact. The results of these studies have defined metabolic consequences of an HBV infection of hepatocytes and will help to lay the groundwork for novel research directions and, potentially, development of novel anti-HBV therapeutics.
登录
查看更多内容
影响因子:
29.4
作者:
El-Serag HB
通讯作者:
El-Serag HB
DOI:
10.1074/jbc.m111.259978
发表时间:
2011-08-26
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
Shin HJ;Park YH;Kim SU;Moon HB;Park DS;Han YH;Lee CH;Lee DS;Song IS;Lee DH;Kim M;Kim NS;Kim DG;Kim JM;Kim SK;Kim YN;Kim SS;Choi CS;Kim YB;Yu DY
通讯作者:
Yu DY
影响因子:
6.7
作者:
Lamontagne J;Mell JC;Bouchard MJ
通讯作者:
Bouchard MJ
影响因子:
3
作者:
Langfelder P;Horvath S
通讯作者:
Horvath S
影响因子:
3.7
作者:
Jagya N;Varma SP;Thakral D;Joshi P;Durgapal H;Panda SK
通讯作者:
Panda SK